Literature DB >> 29633539

Longterm Analysis of Biliary Complications After Duct-to-Duct Biliary Reconstruction in Living Donor Liver Transplantations.

Sung Yeon Hong1, Xu-Guang Hu1, Hyun Young Lee2, Je Hwan Won3, Jin Woo Kim3, Xue-Yin Shen1, Hee-Jung Wang1, Bong-Wan Kim1.   

Abstract

Biliary complication (BC) is still regarded as the Achilles' heel of a living donor liver transplantation (LDLT). This study aims to evaluate the longterm outcomes of the duct-to-duct (DD) biliary reconstruction using 7-0 suture and to identify the risk factors of BCs after LDLTs. Data of 140 LDLTs between 2006 and 2015 were analyzed. All biliary reconstructions were performed as DD anastomoses using 7-0 suture: 102 for the right lobe, 20 for the left lobe, and 18 for right posterior sector grafts. BC was defined as a bile leakage (BL) or a biliary stricture (BS), and the median follow-up time after LDLT was 65 months. A total of 19 recipients (13.5%) developed BCs (8 BLs and 16 BSs) after LDLT. The survival rates between recipients with and without BCs were 83% and 86.7%, respectively (P = 0.88). In univariate analyses, the risk factors for BC were small diameter of the graft's bile duct, long warm ischemic time, small graft-to-recipient weight ratio, and no use of external biliary stent (EBS). The graft's bile duct diameter ≤ 3 mm and no use of EBS were determined as independent risk factors (hazard ratios of 9.74 and 7.68, respectively) in multivariate analyses. The 116 recipients with EBS had no BL, 11 had BSs (9%), while 24 without EBS had 8 BLs (33%) and 5 BSs (21%). After a propensity score match between the recipients with and without EBS, the EBS group (24) developed only 1 BS (4%). In conclusion, DD anastomosis using 7-0 suture combined with EBS could provide favorable longterm outcomes after LDLT, which should thus be considered the surgical technique of choice for LDLTs.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29633539     DOI: 10.1002/lt.25074

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

1.  Biliary complications after adult to adult right-lobe living donor liver transplantation (A-ARLLDLT): Analysis of 245 cases during 16 years period at a single high centre- A retrospective cohort study.

Authors:  Emad Hamdy Gad; Eslam Ayoup; Amr M Aziz; Tarek Ibrahim; Mostafa Elhelbawy; Mohammed Al-Sayed Abd-Elsamee; Ahmed Nabil Sallam
Journal:  Ann Med Surg (Lond)       Date:  2022-04-14

2.  Bile duct reconstruction using scaffold-free tubular constructs created by Bio-3D printer.

Authors:  Takashi Hamada; Anna Nakamura; Akihiko Soyama; Yusuke Sakai; Takayuki Miyoshi; Shun Yamaguchi; Masaaki Hidaka; Takanobu Hara; Tota Kugiyama; Mitsuhisa Takatsuki; Akihide Kamiya; Koichi Nakayama; Susumu Eguchi
Journal:  Regen Ther       Date:  2021-02-24       Impact factor: 3.419

3.  Biliary complications in recipients of living donor liver transplantation: A single-centre study.

Authors:  Reginia Nabil Guirguis; Ehab Hasan Nashaat; Azza Emam Yassin; Wesam Ahmed Ibrahim; Shereen A Saleh; Mohamed Bahaa; Mahmoud El-Meteini; Mohamed Fathy; Hany Mansour Dabbous; Iman Fawzy Montasser; Manar Salah; Ghada Abdelrahman Mohamed
Journal:  World J Hepatol       Date:  2021-12-27

4.  Reconstruction of Separated Intrahepatic Ducts Using the Cystic and Common Hepatic Ducts in Right-Lobe Living-Donor Liver Transplantation: Experiences of Surgical Techniques, Biliary Complications, and Outcomes in a Single Institution.

Authors:  Po-Jung Hsu; Hao-Chien Hung; Ching-Sung Lee; Kuang-Tse Pan; Jin-Chiao Lee; Yu-Chao Wang; Chih-Hsien Cheng; Tsung-Han Wu; Chen-Fang Lee; Hong-Shiue Chou; Kun-Ming Chan; Wei-Chen Lee; Ting-Jung Wu
Journal:  Ann Transplant       Date:  2022-01-05       Impact factor: 1.530

5.  Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation.

Authors:  Min Seob Kim; Suk Kyun Hong; Hye Young Woo; Jae-Hyung Cho; Jeong-Moo Lee; Kyung Chul Yoon; YoungRok Choi; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Transpl Int       Date:  2022-04-22       Impact factor: 3.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.